Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct Cardiac Connexin-43 Expression in Hypertrophied and Atrophied Myocardium May Impact the Vulnerability of the Heart to Malignant Arrhythmias. A Pilot Study.

Physiological research·2023
Same author

Red palm oil supplementation does not increase blood glucose or serum lipids levels in Wistar rats with different thyroid status.

Physiological research·2018
Same author

Modulation of systemic and aortic nitric oxide by melatonin and n-3 polyunsaturated fatty acids in isoproterenol affected spontaneously hypertensive and normotensive Wistar rats.

Physiological research·2016
Same author

Preventive and therapeutic application of molecular hydrogen in situations with excessive production of free radicals.

Physiological research·2016
Same author

Disordered myocardial Ca(2+) homeostasis results in substructural alterations that may promote occurrence of malignant arrhythmias.

Physiological research·2016
Same author

Protection of cardiac cell-to-cell coupling attenuate myocardial remodeling and proarrhythmia induced by hypertension.

Physiological research·2016
Same journal

Mechanosensitive Ion Channels in Cardiovascular Physiology.

Experimental and clinical cardiology·2016
Same journal

Detection of left ventricular asynchrony and its relationship with the Tei index in patients with coronary artery ectasia.

Experimental and clinical cardiology·2013
Same journal

Smooth muscle-like cells resident in the media participate in spasm-induced coronary intimal hyperplasia.

Experimental and clinical cardiology·2013
Same journal

Omega-3 polyunsaturated fatty acid-enriched diet differentially protects two subpopulations of myocardial mitochondria against Ca(2+)-induced injury.

Experimental and clinical cardiology·2013
Same journal

Cocaine-induced coronary stent thrombosis.

Experimental and clinical cardiology·2013
Same journal

What lies beneath: Posterior ST elevation myocardial infarction with underlying right ventricular-paced rhythm.

Experimental and clinical cardiology·2013
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
07:56

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

Factors determining spontaneous ventricular defibrillation.

N Tribulova1, M Manoach

  • 1Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic, and.

Experimental and Clinical Cardiology
|April 30, 2010
PubMed
Summary
This summary is machine-generated.

Spontaneous ventricular defibrillation (SVD) is facilitated by enhanced intercellular coupling and synchronization, not prolonged action potential duration. New cardioprotective drugs should focus on calcium regulation to promote SVD.

Keywords:
Antiarrhythmic/defibrillating compoundsCa2+ overloadIntercellular couplingSpontaneous ventricular defibrillationVentricular fibrillation

More Related Videos

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

Related Experiment Videos

Last Updated: Jun 13, 2026

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
07:56

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • Ventricular fibrillation (VF) is a fatal arrhythmia requiring defibrillation.
  • Traditional VF criteria focused on wavelength theory, suggesting prolonged action potential duration (APD) and effective refractory period (ERP) aid defibrillation.
  • Recent studies challenge this, indicating APD prolongation can be proarrhythmic.

Purpose of the Study:

  • To investigate the mechanisms underlying spontaneous ventricular defibrillation (SVD).
  • To re-evaluate the role of APD and effective refractory period (ERP) in VF and SVD.
  • To propose a novel approach for developing cardioprotective-defibrillating drugs.

Main Methods:

  • Comparative analysis of transient and sustained VF in various mammals.
  • Evaluation of anti-arrhythmic properties of defibrillating compounds.
  • Assessment of the role of intercellular coupling, synchronization, and calcium (Ca2+) overload.

Main Results:

  • SVD appears to require high myocardial gap junctional coupling and synchronization.
  • Excess cytoplasmic free Ca2+ concentration is linked to intercellular uncoupling.
  • Defibrillating drugs prevent or attenuate Ca2+ overload, enhancing coupling and facilitating SVD.

Conclusions:

  • Prolongation of APD or ERP may facilitate arrhythmias and VF.
  • Enhancing intercellular coupling and synchronization, while decreasing refractoriness dispersion without prolonging APD, can facilitate SVD.
  • Future cardioprotective-defibrillating drug development should target improved intercellular coupling and calcium regulation.